bioAffinity Technologies, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
BIAF, BIAFW on Nasdaq
Location
22211 West Interstate 10, Suite 1206, San Antonio, TX

There are no Buy or Sell transactions made by insiders since 11/5/2023

bioAffinity Technologies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gary D. Rubin Director, 10%+ Owner $4.59M Jul 1, 2024
Steven Girgenti Executive Chairman, Director $2.85M Jul 1, 2024
Nathan Perlmutter 10%+ Owner $2.21M Sep 6, 2022
Roby Joyce Director $1.72M Jul 1, 2024
Maria Zannes President & CEO, Director $645K Jul 1, 2024
Robert A. Anderson Director $434K Jul 1, 2024
Peter S. Knight Director $311K Jul 1, 2024
Stuart Diamond Director $263K Jul 1, 2024
Mohsin Y. Meghji Director $162K Oct 1, 2023
Jamie Platt Director $145K Jul 1, 2024
Michael Dougherty Chief Financial Officer $125K Jan 31, 2024
Timothy P. Zannes Secretary, EVP, Gen. Counsel $119K Apr 4, 2024
Vivienne Rebel Chief Sci. & Med. Officer, EVP $68.4K Jan 31, 2024
James Michael Edwards Interim CFO $37K Sep 16, 2024
Xavier T. Reveles Chief Operating Officer $30.1K Jan 31, 2024

Recent Insider Transactions by Companies or Individuals for bioAffinity Technologies, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.